TrialStroke2014

Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial.

William N Whiteley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.